Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Parasomnias × Cannabidiol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Sturge-Weber Syndrome 2 Nausea 2 Vomiting 1 Tuberous Sclerosis 1 Seizures 1 Parasomnias 1 Pain 1 Neoplasms 1 Marijuana Abuse 1 Dysgeusia 1 Drug Resistant Epilepsy 1 Cognitive Dysfunction 1 Chemotherapy-Induced Peripheral Neuropathy 1 Cachexia 1 Breast Neoplasms 1 Arthralgia 1 Appetitive Behavior 1 Anxiety Disorders 1

Interventions

Surveys and Questionnaires 3 Melatonin 3 Yoga 2 Exercise 2 Control Groups 2 nabiximols 1 Sugars 1 Modafinil 1 Minocycline 1 Mindfulness 1 Massage 1 Exercise Movement Techniques 1 Dronabinol 1 Cannabidiol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03948074 2025-09-10

CAFCARS

British Columbia Cancer Agency

Phase 2 Completed

Anxiety Disorders, Nausea, Pain, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡